GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

BACKGROUND: First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in newly diagnosed high-risk (HR) patients. METHODS: This was a prospective, multicentric, non-randomised, open study for patients ⩽40 years with n...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Br J Cancer
Main Authors:	Mora, J, Castañeda, A, Perez-Jaume, S, Lopez-Pousa, A, Maradiegue, E, Valverde, C, Martin-Broto, J, Garcia del Muro, X, Cruz, O, Cruz, J, Martinez-Trufero, J, Maurel, J, Vaz, M A, de Alava, E, de Torres, C
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group 2017
Fag:	Clinical Study
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5589997/ https://ncbi.nlm.nih.gov/pubmed/28787430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.252
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

Lignende værker